OTC Markets OTCPK - Delayed Quote USD
Bavarian Nordic A/S (BVNRY)
At close: November 6 at 3:56 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,082,629.00
7,062,340.00
3,150,793.00
1,897,875.00
1,852,383.00
Cost of Revenue
2,620,952.00
2,459,294.00
1,449,531.00
1,327,560.00
1,195,094.00
Gross Profit
3,461,677.00
4,603,046.00
1,701,262.00
570,315.00
657,289.00
Operating Expense
2,738,105.00
3,100,507.00
1,772,047.00
883,862.00
277,701.00
Operating Income
723,572.00
1,502,539.00
-70,785.00
-313,547.00
379,588.00
Net Non Operating Interest Income Expense
-74,636.00
-63,015.00
-65,273.00
-118,136.00
-109,090.00
Pretax Income
715,654.00
1,482,943.00
-331,611.00
-454,430.00
281,976.00
Tax Provision
8,234.00
7,754.00
15,771.00
10,345.00
4,455.00
Net Income Common Stockholders
707,420.00
1,475,189.00
-347,382.00
-464,775.00
277,521.00
Diluted NI Available to Com Stockholders
707,420.00
1,475,189.00
-347,382.00
-464,775.00
277,521.00
Basic EPS
3.00
6.40
-1.63
-2.47
1.70
Diluted EPS
3.00
6.40
-1.63
-2.47
1.70
Basic Average Shares
232,568.24
230,131.68
211,255.17
189,312.00
162,138.00
Diluted Average Shares
232,568.24
230,131.68
211,255.17
189,312.00
162,138.00
Total Expenses
5,359,057.00
5,559,801.00
3,221,578.00
2,211,422.00
1,472,795.00
Net Income from Continuing & Discontinued Operation
707,420.00
1,475,189.00
-347,382.00
-464,775.00
277,521.00
Normalized Income
698,088.61
1,433,490.54
-185,081.94
-434,311.32
268,316.66
Interest Income
51,358.00
40,214.00
26.00
1,739.00
193.00
Interest Expense
96,294.00
105,519.00
119,689.00
152,060.00
177,002.00
Net Interest Income
-74,636.00
-63,015.00
-65,273.00
-118,136.00
-109,090.00
EBIT
811,948.00
1,588,462.00
-211,922.00
-302,370.00
458,978.00
EBITDA
1,414,948.00
2,142,283.00
187,325.00
85,940.00
819,125.00
Reconciled Cost of Revenue
2,620,952.00
2,459,294.00
1,449,531.00
1,327,560.00
1,195,094.00
Reconciled Depreciation
603,000.00
553,821.00
399,247.00
388,310.00
360,147.00
Net Income from Continuing Operation Net Minority Interest
707,420.00
1,475,189.00
-347,382.00
-464,775.00
277,521.00
Total Unusual Items Excluding Goodwill
9,440.00
41,908.00
-208,077.00
-39,056.00
9,354.00
Total Unusual Items
9,440.00
41,908.00
-208,077.00
-39,056.00
9,354.00
Normalized EBITDA
1,405,508.00
2,100,375.00
395,402.00
124,996.00
809,771.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
108.61
209.54
-45,776.94
-8,592.32
149.66
12/31/2020 - 8/15/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GMAB Genmab A/S
22.33
-1.85%
GOVX GeoVax Labs, Inc.
1.8300
+0.55%
HNSA.ST Hansa Biopharma AB (publ)
33.12
+2.48%
GMAB.CO Genmab A/S
1,557.00
+2.20%
ALK-B.CO ALK-Abelló A/S
156.30
-1.57%
GUBRA.CO Gubra A/S
417.00
-3.25%
ZEAL.CO Zealand Pharma A/S
835.00
-2.57%
HTD.BE Corcept Therapeutics Inc
50.04
+2.08%
HTD.F Corcept Therapeutics Incorporated
49.99
+1.87%
EVAX Evaxion Biotech A/S
2.5700
-1.53%